Supernus Pharmaceuticals | Ativo Circulante



Current Assets Alterar Data
Abbott USD 24.47B 1.32B 2025-06
ANI Pharmaceuticals USD 602.63M 66.34M 2025-06
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Eisai JPY 763.15B 35.49B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Novo Nordisk 162.71B 11.69B 2025-06
Pacira USD 745.61M 14.35M 2025-06
Perrigo USD 2.62B 82M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12


Supernus Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.